Results 181 to 184 of about 5,497 (184)

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Lancet, The, 2002
Stephen B Hanauer
exaly  

Genetics of Crohn disease, an archetypal inflammatory barrier disease

Nature Reviews Genetics, 2005
Stefan Schreiber, Philip Rosenstiel, Mario Albrecht   +2 more
exaly  

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial

Gut, 2012
Bruce E Sands, Marc Vandemeulebroecke, Peter D R Higgins   +2 more
exaly  

Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial

Lancet, The, 2016
Damián García-Olmo, Gert Van Assche, Walter Reinisch   +2 more
exaly